JBIO
Jade Biosciences
JBIO
JBIO
77 hedge funds and large institutions have $841M invested in Jade Biosciences in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 18 increasing their positions, 23 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 2.91% → 2.92% (+0%)
22% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 23
Holders
77
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$12.8M | |
| 2 | +$10.9M | |
| 3 | +$5.91M | |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$4.14M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$3.26M |
Top Sellers
| 1 | -$9.05M | |
| 2 | -$7.78M | |
| 3 | -$5.66M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$4.43M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.2M |